Infusion of the cholinomimetic drug physostigmine led to profound
increases in serum epinephrine levels and slight increases in serum
norepinephrine levels among 38 patients with affective disorder and 22
control subjects. Preliminary results suggest that physostigmine may induce
relatively blunted increases in serum epinephrine levels in patients with
affective disorders.Abstract Teaser